Mednet Logo

How do you manage elderly patients with borderline PS and ER+ inflammatory breast cancer without metastasis?

Would you consider neo-adjuvant chemotherapy or treat with endocrine therapy?
1 Answer
Mednet Member
Mednet MemberInvited Expert
Medical Oncology · Yale
Answered on

Consideration of chemotherapy in this particular case will depend on a number of factors including: specific commodities, cardiac risk factors , and overall performance status. CARG tox calculator may help in teasing out potential for toxicity vs. benefit from treatment. Biological characteristics o...

Join for free or sign in to see the full answer